What This Dividend Ratio Is Telling Us Now

By Owain Bennallack | More Articles
November 29, 2012 | Comments (1)

LONDON -- Owain Bennallack and Maynard Paton discuss the difference between the dividend yield of the FTSE 100 (INDEX: ^FTSE ) and the current income from government bonds. This "yield gap" ratio has signaled buying opportunities before, but what does it tell us now? Companies mentioned include BP (LSE: BP ) , GlaxoSmithKline (LSE: GSK ) and Vodafone (LSE: VOD ) .

If you like high-yield FTSE shares, this special free report reviews the favorite income stocks held by Neil Woodford -- the City fund manager who has thrashed the market by favoring dividend-paying blue chips. Just click here to download these Neil Woodford income ideas today.

link

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.

Report this Comment On November 30, 2012, at 8:51 AM, popsranola wrote:

You had a good point stocks is better than gilts and Vodafone, BP and Glaxosmithkline is far better holding than gilts..........In terms of dividend and Income...............It is like a milking cow the in growth plus dividends assurance for the next 10 years..........

updated 2 days ago Sponsored by:
	DOW	15,354.40	121.18	0.80%
	S&P 500	1,667.47	17.00	1.03%
	NASD	3,498.97	33.73	0.97%

VOD	$198.06		+1.01	+0.51%
Vodafone Group		CAPS Rating:

GSK	$1712.50		+5.00	+0.29%
GlaxoSmithKline		CAPS Rating:

BP	$469.55		+3.75	+0.81%
BP		CAPS Rating:

My Watchlist

2

What This Dividend Ratio Is Telling Us Now

Comments from our Foolish Readers

Report this Comment On November 30, 2012, at 8:51 AM, popsranola wrote:

Add your comment.

Compare Brokers

Report This Comment

Sending report...

Today's Market

Create My Watchlist

You don't seem to be following any stocks yet!

Related Tickers